Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Margareta Nordlander"'
Publikováno v:
European Journal of Pharmacology. 565:138-143
Excessive sympathetic activity is believed to be the key arrhythmogenic factor both in the setting of acute myocardial infarction and during chronic heart failure. The aim of this study was to evaluate the effect of neuropeptide Y2 blockade on malign
Autor:
Trude Aspelin, Morten Eriksen, Jan-Arne Björkman, Arnfinn Ilebekk, Margareta Nordlander, Knut Sevre, Torstein Lyberg
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 11:177-183
Neuropeptide Y is released together with norepinephrine from sympathetic nerve terminals during conditions of increased sympathetic activity. Neuropeptide Y is known to inhibit vagal activity, and accordingly, it might increase the risk for ventricul
Autor:
C. Naughton, R.D. Latimer, R. O. Feneck, Margareta Nordlander, S. L. Misso, A. V. V. Powroznyk, Alain Vuylsteke, Åse Jolin-Mellgård, J. Holloway
Publikováno v:
European Journal of Anaesthesiology. 20:697-703
Background and objective We set out to compare the efficacy of clevidipine and sodium nitroprusside infusions in the control of blood pressure and the haemodynamic changes they produce in hypertensive patients after operation for elective coronary by
Autor:
Margareta Nordlander, Ann-Cathrine Jönsson-Rylander, Bengt Hallberg, Yihai Cao, Renhai Cao, Hessameh Hassani, Susanne Nyström, Meit A. Björndahl, A. Jonas Ekstrand
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2003, 100, pp.6033-6038
Proceedings of the National Academy of Sciences of the United States of America, 2003, 100, pp.6033-6038
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2003, 100, pp.6033-6038
Proceedings of the National Academy of Sciences of the United States of America, 2003, 100, pp.6033-6038
Neuropeptide Y (NPY), a 36-aa peptide, is widely distributed in the brain and peripheral tissues. Whereas physiological roles of NPY as a hormone/neurotransmitter have been well studied, little is known about its other peripheral functions. Here, we
Autor:
Wei Lu, Jerrold H. Levy, James Ramsay, Neil W. Brister, James M. Bailey, Åse Jolin-Mellgård, Linda Shore-Lesserson, Margareta Nordlander, Richard C. Prielipp, G. Roach
Publikováno v:
Anesthesiology. 96:1086-1094
Background Treatment of elevated blood pressure is frequently necessary after cardiac surgery to minimize postoperative bleeding and to attenuate afterload changes associated with hypertension. The purpose of this study was to investigate the pharmac
Autor:
Margareta Nordlander, D. Mur, R.D. Latimer, Åse Jolin-Mellgård, Alain Vuylsteke, John Dunning, Q. Milner, Hans Ericsson
Publikováno v:
British Journal of Anaesthesia. 85:683-689
Clevidipine is a new vascular-selective, calcium channel antagonist of the dihydropyridine type with an ester side chain susceptible to esterase metabolism. In healthy volunteers, it has high clearance (0.069 litres min-1 kg-1) with a small volume of
Autor:
Margareta Nordlander, Per Nyström, R. O. Feneck, Alain Vuylsteke, Sven-Erik Ricksten, Carl Lynch, Jerrold H. Levy, Åse Jolin-Mellgård, R.D. Latimer
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 14:269-273
Objective: To conduct a survey of current cardiac anesthetic practice in Europe and the United States, as a first step toward establishing guidelines for the management of perioperative hypertension. Design: Prospective, multicenter study. Setting: U
Autor:
Hans Ericsson, Margareta Nordlander, Carl Gunnar Regårdh, Åse Jolin-Mellgård, Ulf G. Eriksson, Ulf Bredberg
Publikováno v:
Anesthesiology. 92:993-1001
Background Clevidipine is an ultra-short-acting calcium antagonist developed for reduction and control of blood pressure during cardiac surgery. The objectives of the current study were to determine the pharmacokinetics of clevidipine after 20-min an
Publikováno v:
Seminars in Cardiothoracic and Vascular Anesthesia. 2:231-242
Calcium entry blockers constitute three major classes of pharmacologic agents: phenylalkylamines (eg, verapa mil), benzothiazepines (eg, diltiazem), and dihydropyri dines (eg, nifedipine). The effectiveness of all types of calcium channel blockers in
Publikováno v:
Anesthesia & Analgesia. 85:1000-1004
Endothelial dysfunction and platelet activation with thromboxane release may contribute to spasm or alterations in internal mammary artery (IMA) graft flow during coronary artery surgery. Clevidipine, an ultrashort-acting dihydropyridine calcium chan